Maryland HB1537 expands newborn screening to include Metachromatic Leukodystrophy.
Maryland HB1537 amends the state's newborn screening program to include testing for Metachromatic Leukodystrophy. The Department of Health will establish a coordinated system for screening all newborns for hereditary and congenital disorders, including performing tests, reporting results, and facilitating follow-up activities. The bill also mandates the Department to adopt federal recommendations on critical congenital heart disease screening and sets protocols for health care providers to obtain and deliver test specimens.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.